Introduction {#section5-1352458519852722}
============

Multiple sclerosis (MS) is characterized by physical and cognitive impairments and by a high burden of depression, anxiety, and fatigue. These impairments and symptoms are associated with reduced health-related quality of life (HRQOL).^[@bibr1-1352458519852722]^ HRQOL is an important patient-reported outcome measure, including in clinical trials of disease-modifying therapies (DMTs).^[@bibr2-1352458519852722]^ Several countries rely on measures such as quality-adjusted life years to assess cost-effectiveness of DMTs and determine if they should be publicly funded. Generic preference-based (utility) measures, such as the Health Utilities Index---Mark III (HUI3) are appropriate for this purpose, whereas health profile measures, such as the Short Form-12 (SF-12) are not. A review of generic utility measures in MS found that the HUI3 had the strongest psychometric properties.^[@bibr3-1352458519852722]^

Researchers studying HRQOL in MS can choose from an array of instruments with variable psychometric properties. A 2003 review of HRQOL identified 6 commonly used generic and 11 disease-specific measures applied in studies of MS populations.^[@bibr1-1352458519852722]^ A more recent systematic review found that 13 different HRQOL measures were used in 28 clinical trials of DMTs.^[@bibr4-1352458519852722]^ The use of multiple instruments limits comparisons across studies and the ability to combine data sets. The National Institutes of Neurological Disorders and Stroke (NINDS) Common Data Elements (CDEs) project has aimed to standardize data collection to address some of these issues generally. However, for MS, the NINDS CDE recommended multiple generic and disease-specific HRQOL measures,^[@bibr5-1352458519852722][@bibr6-1352458519852722][@bibr7-1352458519852722][@bibr8-1352458519852722][@bibr9-1352458519852722]--[@bibr10-1352458519852722]^ including the SF-12. Thus it is likely that studies including HRQOL as an outcome will continue to use a variety of instruments.

The SF-12 and RAND-12^[@bibr11-1352458519852722]^ use the same 12 questions, and each generates two aggregate scores for physical (Physical Component Score-12 (PCS-12)) and mental health (Mental Component Score-12 (MCS-12); however, they are scored differently. Like the Short Form-36 from which it is derived, the SF-12's summary scores are based on principle component analysis with orthogonal factor rotations. In contrast, the RAND-12 uses item-response theory (IRT)-based scaling and oblique factor rotations to generate its summary scores.^[@bibr12-1352458519852722]^ The alternative RAND-12 scoring better assesses mental health in MS than the scoring used for the SF-12.^[@bibr13-1352458519852722]^ Therefore, the North American Research Committee on Multiple Sclerosis (NARCOMS) registry has used the RAND-12 to assess HRQOL for over a decade; it has been used by other investigators to study MS and other chronic diseases.^[@bibr13-1352458519852722][@bibr14-1352458519852722]--[@bibr15-1352458519852722]^ Given the psychometric strengths of the HUI3, increasing interest in data harmonization, and the general lack of crosswalks between HRQOL instruments commonly used in MS, we developed a crosswalk that associates scores from the RAND-12 to corresponding scores on the HUI3 in persons with MS.

Methods {#section6-1352458519852722}
=======

NARCOMS {#section7-1352458519852722}
-------

The NARCOMS registry is a self-report registry for persons with MS which began enrolling participants in 1996. Since 2000, the registry has administered semi-annual surveys. Several studies have established the validity of self-reported diagnoses of MS and of the disability measures used.^[@bibr16-1352458519852722][@bibr17-1352458519852722][@bibr18-1352458519852722]--[@bibr19-1352458519852722]^ Participants agree to use of their de-identified information for research. The NARCOMS registry and its surveys are approved by the Institutional Review Board (IRB) at Washington University in St. Louis.

Demographic and clinical information {#section8-1352458519852722}
------------------------------------

We obtained demographics from the enrollment survey (sex, date of birth, and education level) and the Spring 2018 Update survey (annual household income and country of residence). Participants reported their level of education as \<high school, high school/GED, Associate's Degree, Bachelor's Degree, Post-graduate education, and Technical degree. Participants reported annual household income as \<\$15,000, \$15,001--\$30,000, \$30,001--\$50,000, \$50,001--\$100,000, \>\$100,000, and "I do not wish to answer."

We obtained ages at symptom onset and diagnosis from the enrollment survey. We obtained disability status from the update survey, using Patient Determined Disease Steps (PDDS). PDDS is a single-item measure with potential responses including 0 (normal), 1 (mild disability), 2 (moderate disability), 3 (gait disability), 4 (early cane), 5 (late cane), 6 (bilateral support), 7 (wheelchair/scooter), and 8 (bedridden). PDDS scores correlate highly with those from a physician-scored Expanded Disability Status Scale.^[@bibr18-1352458519852722]^

HRQOL {#section9-1352458519852722}
-----

In the Spring 2018 survey, we measured HRQOL using the RAND-12 and the HUI3. The RAND-12 is an abbreviated version of the RAND-36, a validated and widely used measure of health status developed for the Medical Outcomes Study.^[@bibr5-1352458519852722],[@bibr11-1352458519852722]^ The RAND-12 includes 12 items, each capturing an aspect of one of the eight subscales of the RAND-36. The RAND-12 generates two aggregate scores which summarize physical HRQOL (PCS-12) and mental HRQOL (MCS-12); all items contribute to each score but differently for the PCS-12 and MCS-12. All reverse scored items are rescored so that higher values always indicate better health, then a scoring algorithm is applied to weight response items, and a sum generated. These scores range from 0 to 100 and are standardized to reflect a general population mean of 50 and standard deviation of 10; higher scores indicate better HRQOL.

The HUI3 is a 15-item, self- or interviewer-administered generic measure of health utility that assesses patient-reported health state with respect to eight attributes: vision, hearing, speech, mobility, dexterity, emotion, cognition, and pain; each has five or six levels ranging from the best to worst possible health states.^[@bibr20-1352458519852722]^ The HUI3 defines 972,000 health states; utility scores reflect preferences for those health states. These single-attribute scores can be aggregated into a multi-attribute utility score measure using a lookup table and mathematical formula; values range from 0 (death) to 1 (perfect health), while values below 0 (up to ‒0.36) reflect health states valued as worse than death.^[@bibr20-1352458519852722]^ The HUI3 has interval-level measurement properties^[@bibr21-1352458519852722]^ and demonstrated reliability and validity in general and disease-specific populations, including MS.^[@bibr22-1352458519852722]^

Analysis {#section10-1352458519852722}
--------

As we sought to develop a crosswalk between the two instruments, the analysis was limited to participants who completed all items for the RAND-12 and HUI3. While the HUI3 produces a single multi-attribute score, the RAND-12 produces two aggregate scores. Therefore, we summed the two RAND-12 aggregate scores for the purposes of linking the two instruments. We modeled our approach on the methods of Choi et al.^[@bibr23-1352458519852722]^ To determine if it was reasonable to link these instruments, we reviewed item content to ensure that the two instruments were measuring the same concept. Second, we evaluated correlations between the instruments. Third, we used two approaches, IRT and equipercentile linking, to create crosswalks.

IRT models are latent trait models which assume that there is an underlying (latent) trait which is normally distributed and influences the likelihood of a particular response to discrete test items. Several assumptions are required for IRT, the most important being that the latent variable of interest is unidimensional. This also implies conditional independence, that is, responses to test items are independent, given the latent variable. We evaluated unidimensionality using confirmatory factor analysis models performed with diagonally weighted least squares (DWLS) based on a polychoric correlation matrix using version 0.6-2 of the lavaan package of R.^[@bibr24-1352458519852722]^ We used DWLS to account for the ordinal measurement scale of the observed items; it produces unbiased estimates of factor loadings regardless of the number of categories for the observed variables, level of distributional asymmetry and sample.^[@bibr25-1352458519852722]^ The unidimensionality assumption also implies conditional independence of instrument items after the latent trait is accounted for. However, when an instrument includes multiple items that assess a common "stimulus" or aspect (e.g. pain and fatigue),^[@bibr26-1352458519852722]^ conditional independence may not occur; this does not prevent the application of IRT. We assessed fit of the confirmatory factor analysis models using root mean square error of approximation (RMSEA) and comparative fit index (CFI). Values for RMSEA range from 0 to 1, with smaller values indicating better fit; values of ⩽0.06 indicate adequate fit.^[@bibr27-1352458519852722]^ Values for CFI range from 0 to 1, and larger values indicate better fit; values of ⩾0.90 indicate acceptable fit.^[@bibr27-1352458519852722]^ We also conducted simple exploratory factor analysis and inspected the scree plot, expecting that the first eigenvector should capture most of the variance if the instrument is unidimensional.

Since all items for both scales are ordinal, we fit the IRT models using the graded response model (i.e. ordinal logistic regression), where the independent variable was the latent score and the dependent variable was the item of interest. The probability of a given response is a function of item characteristics and the unobserved value of the latent trait. Under the assumption of conditional independence, latent trait values can then be estimated for each unique observed scale response pattern. Thus, for each scale, we predicted the participants' scale scores using a non-linear model (with a cubic spline) with the estimated latent trait as the independent variable. This means that a given latent trait value will have two predictions associated with it, one for each scale, and these are linked to create a crosswalk.^[@bibr26-1352458519852722]^ This process is known as true-score equating.^[@bibr28-1352458519852722]^ IRT models were estimated using version 1.1-1 of the ltm package in R.^[@bibr29-1352458519852722]^

Equipercentile linking is a non-parametric approach which involves the calculation of scores for each instrument and then obtaining the score's percentile rank in the study sample. Scores with equivalent percentile ranks for each instrument are then associated. The distribution of scores for each instrument was smoothed with log-linear models before equating, which reduces sampling errors. Analyses were performed using version 2.0.7 of the equate package of R.^[@bibr30-1352458519852722]^

We assessed the performance of both approaches by comparing predicted scores from each crosswalk for the HUI3 to actual (observed) HUI3 scores using (1) Pearson correlations between the predicted and actual scores; (2) concordance using intraclass correlation coefficients (ICCs) between the predicted and actual scores; (3) assessing bias using Bland--Altman plots. Finally, for the equipercentile linking (the superior approach as delineated in the results), we assessed bootstrap standard errors, that is, the standard deviation of the predicted value of the HUI3 over repeated random samples. This provided an estimate of the sampling variability of the predictions.

Complementary analysis {#section11-1352458519852722}
----------------------

We applied equipercentile linking, our preferred method, to create crosswalks for the PCS-12 and MCS-12 scores and the HUI3.

Results {#section12-1352458519852722}
=======

Participants {#section13-1352458519852722}
------------

Of 11,389 invited participants, 7129 (62.6%) responded. As compared to non-responders, responders were more likely to be White (*p* \< 0.0001), had a higher level of education (*p* \< 0.0001), and were on average 1 year older at diagnosis (*p* \< 0.0001). Of those who responded, 6348 answered all of the questions for the SF-12 and for the HUI3 and were included in the analysis. Most responders were women, White, and had more than a high school education with a spectrum of disability ([Table 1](#table1-1352458519852722){ref-type="table"}).

###### 

Clinical and demographic characteristics of study participants (*n* = 6348).

![](10.1177_1352458519852722-table1)

  Characteristics                                                                           Value
  ----------------------------------------------------------------------------------------- -------------
  Age at time of study, mean (SD)                                                           60.7 (10.4)
  Age at MS symptom onset, mean (SD)                                                        31.1 (10.2)
  Age at MS diagnosis, mean (SD)                                                            39.1 (9.9)
  Female sex, *n* (%)                                                                       5091 (80.3)
  Race^[a](#table-fn1-1352458519852722){ref-type="table-fn"}^, *n* (%)                      
   White                                                                                    5508 (87.4)
   Non-White                                                                                793 (12.6)
  Education^[b](#table-fn2-1352458519852722){ref-type="table-fn"}^, *n* (%)                 
   High school                                                                              1602 (27.0)
   Associate's degree                                                                       877 (14.8)
   Bachelor's degree                                                                        1766 (29.8)
   Post-graduate degree                                                                     1526 (25.8)
   Technical degree                                                                         156 (2.6)
  Annual household income^[c](#table-fn3-1352458519852722){ref-type="table-fn"}^, *n* (%)   
   Less than \$15,000                                                                       380 (6.1)
   \$15,001--\$30,000                                                                       772 (12.3)
   \$30,001--\$50,000                                                                       952 (15.2)
   \$50,001--\$100,000                                                                      1538 (24.6)
   Over \$100,000                                                                           1214 (19.4)
   I do not wish to answer                                                                  1398 (22.4)
  PDDS, median (p25--p75)                                                                   4 (1--6)

A total of 47 did not report race.

A total of 421 did not report education level.

A total of 94 did not report income.

Item content overlap and correlations between instruments {#section14-1352458519852722}
---------------------------------------------------------

With respect to item content overlap, both the HUI3 and RAND-12 have items that assess mood, pain, and activity limitations. The RAND-12 captures fatigue, which the HUI3 does not. The HUI3 explicitly captures specific domains of physical or cognitive impairment (vision, hearing, speaking, mobility, upper limb, and cognition), while the RAND-12 focuses on the impact of physical limitations rather than the specific domain which is impaired.

Histograms for the HUI3 and RAND-12 showed some skewness but were approximately normal. The mean (SD) score on the HUI3 was 0.44 (0.33), on the PCS-12 was 37.5 (11.6) and on the MCS-12 was 46.6 (11.3). The HUI3 was moderately correlated with the PCS-12 (*r* = 0.66; 95% confidence interval (CI): 0.65, 0.67), but the correlation with the MCS-12 was weaker (*r* = 0.46; 95% CI: 0.44, 0.48). Internal consistency, as measured by Cronbach's alpha, was acceptable for both instruments ([Table 2](#table2-1352458519852722){ref-type="table"}). On the HUI3, 62 (0.98%) of participants scored the maximum value of 1, and no participants scored the minimum value. On the PCS-12, no participants scored the maximum or minimum possible values; notably the highest score was 65.9. On the MCS-12, no participants scored the minimum or maximum possible values; the highest score was 74.8.

###### 

Internal consistency reliability of the health-related quality of life instruments.

![](10.1177_1352458519852722-table2)

                              RAND-12             HUI3
  --------------------------- ------------------- -------------------
  Number of scored items      12                  15
  Cronbach's alpha (95% CI)   0.91 (0.90, 0.92)   0.81 (0.80, 0.82)
  Item-total correlation                          
   Minimum                    0.46                0.26
   Mean                       0.64                0.42
   Maximum                    0.80                0.58

HUI3: Health Utilities Index---Mark III.

Assessment of unidimensionality {#section15-1352458519852722}
===============================

When we examined unidimensionality for the HUI3 using confirmatory factor analysis, the model fit poorly as measured by the RMSEA (0.136) and CFI (0.892). This appeared to be due to conditional dependence between some items, including items 3 and 4, which assess hearing, items 5 and 6, which assess speech, items 9 and 10, which assess upper and lower limb physical impairments, and items 11 and 12, which assess cognition. Accounting for these reasonable dependencies by including the correlations between those items in the model improved fit to acceptable levels (RMSEA = 0.044, CFI = 0.99).

When we examined unidimensionality for the RAND-12 using confirmatory factor analysis, the model fit poorly as measured by the RMSEA (0.215) as well as measured by the CFI (0.971). This appeared to be due to conditional dependence between some items, including two items which assess the impact of emotional problems, two items which assess mood and four items which assess the impact of physical or emotional problems on function. However, accounting for these reasonable dependencies by including the correlations between those items in the model did not improve model fit to acceptable levels (RMSEA = 0.13, CFI = 0.99). This prompted the use of a restricted bifactor model, in which a general underlying latent construct is retained, along with several smaller latent subfactors.^[@bibr31-1352458519852722]^ All items load onto the general factor and also onto only one of the subfactors (in our case were the PCS-12 and MCS-12 scales). This model fit well (RMSEA = 0.064, CFI = 0.998) with the general factor explaining 69% of the common variance. These fit statistics indicated that there is a strong underlying general factor, and thus the RAND-12 was sufficiently unidimensional to move forward with the linking of the RAND-12 and the HUI3.

IRT-based linking {#section16-1352458519852722}
=================

[Supplemental Table e1](https://journals.sagepub.com/doi/suppl/10.1177/1352458519852722) shows the crosswalk produced by linking the RAND-12 and HUI3 using the IRT-based approach. The predicted and observed values from the IRT-based approach were moderately correlated (Pearson *r* = 0.76) with moderate concordance (ICC = 0.72). The Bland--Altman plots showed an asymmetric distribution suggesting biased prediction, which was not constant across the range of HUI3 values ([Figure 1](#fig1-1352458519852722){ref-type="fig"}).

![Bland--Altman plot of observed versus predicted values of the Health Utilities Index---Mark III (HUI3) using IRT linking.\
Red line indicates no prediction error. The teal line indicates the average disagreement value.](10.1177_1352458519852722-fig1){#fig1-1352458519852722}

Equipercentile linking {#section17-1352458519852722}
======================

[Table 3](#table3-1352458519852722){ref-type="table"} shows the crosswalk produced by linking the RAND-12 and HUI3 using equipercentile linking. The predicted and observed values from the equipercentile method were moderately correlated (Pearson *r* = 0.78, ICC = 0.78). The Bland--Altman plots showed a reasonably symmetric distribution suggesting no bias. However, some residuals remain large, indicating poor prediction for some scores ([Figure 2](#fig2-1352458519852722){ref-type="fig"}). The bootstrap standard errors were lower at the extremes of the RAND-12 scale, suggesting some variation in the predictive accuracy of the crosswalk ([Table 3](#table3-1352458519852722){ref-type="table"}).

###### 

Crosswalk between the RAND-12 and Health Utilities Index---Mark III (HUI3) using equipercentile ranking.

![](10.1177_1352458519852722-table3)

  RAND-12   Estimated HUI3   Bootstrap standard error
  --------- ---------------- --------------------------
  40        --0.350597       0.09379
  41        --0.340881       0.26392
  42        --0.329695       0.42284
  43        --0.317169       0.55776
  44        --0.303605       0.66713
  45        --0.289285       0.75033
  46        --0.274133       0.80759
  47        --0.258641       0.84467
  48        --0.242651       0.8621
  49        --0.226359       0.86664
  50        --0.209932       0.85902
  51        --0.193221       0.84348
  52        --0.176401       0.82374
  53        --0.159519       0.80045
  54        --0.14246        0.77629
  55        --0.125267       0.75283
  56        --0.108086       0.73064
  57        --0.090751       0.71067
  58        --0.073273       0.69384
  59        --0.055688       0.68031
  60        --0.03803        0.67026
  61        --0.02021        0.66349
  62        --0.002229       0.66005
  63        0.015917         0.65962
  64        0.034211         0.66168
  65        0.052667         0.66579
  66        0.071321         0.67148
  67        0.090176         0.67853
  68        0.10924          0.68663
  69        0.12852          0.6955
  70        0.14802          0.70485
  71        0.167746         0.71453
  72        0.187701         0.72445
  73        0.207888         0.73457
  74        0.228304         0.74491
  75        0.248948         0.75551
  76        0.269811         0.76645
  77        0.290885         0.77778
  78        0.312156         0.78958
  79        0.333608         0.80187
  80        0.35522          0.81467
  81        0.376973         0.82791
  82        0.398841         0.84143
  83        0.420795         0.85505
  84        0.442806         0.86845
  85        0.464844         0.88128
  86        0.486882         0.89306
  87        0.508887         0.90334
  88        0.530825         0.91163
  89        0.552669         0.91744
  90        0.574388         0.9203
  91        0.595958         0.91984
  92        0.617352         0.91575
  93        0.63854          0.90786
  94        0.659497         0.8961
  95        0.680196         0.88056
  96        0.700612         0.86143
  97        0.720716         0.83898
  98        0.740478         0.81358
  99        0.759866         0.78564
  100       0.778843         0.75557
  101       0.797373         0.72375
  102       0.815413         0.6905
  103       0.83292          0.65611
  104       0.849844         0.62074
  105       0.866136         0.58451
  106       0.881743         0.54743
  107       0.896614         0.50963
  108       0.910692         0.47097
  109       0.923931         0.43156
  110       0.936276         0.39142
  111       0.947684         0.3506
  112       0.95812          0.3092
  113       0.967554         0.26737
  114       0.97597          0.22527
  115       0.983366         0.18316
  116       0.989759         0.14128
  117       0.995184         0.09976
  118       0.999697         0.05899
  119       1.003366         0.01938

![Bland--Altman plot of observed versus predicted values of the Health Utilities Index---Mark III (HUI3) using equipercentile linking.\
Red line indicates no prediction error. The teal line indicates the average disagreement value.](10.1177_1352458519852722-fig2){#fig2-1352458519852722}

Complementary analysis {#section18-1352458519852722}
======================

[Supplemental Table e2](https://journals.sagepub.com/doi/suppl/10.1177/1352458519852722) shows the crosswalks produced by linking the MCS-12 and HUI3, and for the PCS-12 and HUI3 using equipercentile linking. The crosswalks produced were not as accurate as the crosswalk based on the combined MCS-12 and PCS-12 scores. When we compared predicted and observed values for the MCS-12 crosswalk, we found that they were moderately correlated (Pearson *r* = 0.46, ICC = 0.46). The Bland--Altman plot showed a reasonably symmetric distribution suggesting no bias (data not shown), but some of the residuals were large. When we compared predicted and observed values for the PCS-12 crosswalk, we found that they were more strongly correlated (Pearson *r* = 0.66, ICC = 0.66 (0.65, 0.67)) than for the MCS-12. The Bland--Altman plot showed a reasonably symmetric distribution suggesting no bias (data not shown), but some of the residuals were large.

Discussion {#section19-1352458519852722}
==========

Interest in data harmonization is increasing, as investigators seek opportunities to pool data to replicate findings, increase statistical power and address novel questions.^[@bibr32-1352458519852722]^ Although data harmonization can be done prospectively, that is, before data are collected, retrospective harmonization is more common. In this situation, comparability of measures collected across different studies must be achieved after data collection. Retrospective harmonization can be particularly challenging when different instruments have been used to measure the same underlying construct because of differences in their measurement properties. We used two different methods to link the RAND-12 to the HUI3 and found that the equipercentile method performed better than IRT linking. We also found that combining the two summary scores of the RAND-12 (MCS-12, PCS-12) produced a more accurate crosswalk with the HUI3 than the crosswalks produced for each of the two component summary scores. The "combined" crosswalk should facilitate future studies that seek to pool data from studies using these two HRQOL measures. Multiple validated instruments exist to assess other key constructs in MS such as depression, and similar approaches could be employed to facilitate harmonization of those instruments.

Previous studies have mapped the SF-12 rather than the RAND-12 to the HUI3 using regression-based methods; both studies had potential limitations with respect to their application in MS. Neither employed an MS population, and the relationship of the RAND-12 and HUI3 may differ in the MS population versus the general population. In 240 individuals attending a community health center in New York, the two component scores of the SF-12 explained about 50% of the variance in the HUI3, and the authors reported a conversion function to generate HUI3 scores given PCS-12 and MCS-12 scores.^[@bibr33-1352458519852722]^ In 8000 persons aged 20--84 years, the general health question of the SF-12 was mapped to the HUI3, adjusting for age and gender. The relationship between the response categories for the general health question and the HUI3 was non-linear.^[@bibr34-1352458519852722]^ The information from the other SF-12 questions was not incorporated into the crosswalk, potentially making the crosswalk less robust. Thus a consistent conversion equation from the complete SF-12 and HUI3 is lacking.

Strengths of this study included the use of a single-group design.^[@bibr35-1352458519852722]^ This allowed us to directly assess the accuracy of the crosswalk by comparing actual and predicted scores. In addition, we developed crosswalks using two different approaches. Our sample was also large, with a range of income, education, and disability levels. Limitations of the study should also be recognized. The linking of the two scales was determined by our sample, which was not population-based, and which did not report the full range of values on either scale, although this was a bigger concern with the RAND-12. Moreover, the standard errors varied across the scale's range indicating variable predictive accuracy. Given the variability of the standard errors and that we did not perform split half-validation of our findings, overfitting is possible; it would be valuable to test the performance of our preferred crosswalk in another sample of people with MS.

We developed a crosswalk between two HRQOL measures, the RAND-12 and the HUI3, in the MS population. This crosswalk will facilitate future data harmonization efforts.

Supplemental Material {#section20-1352458519852722}
=====================

###### MSJ852722_supplemental_material -- Supplemental material for Developing a crosswalk between the RAND-12 and the health utilities index for multiple sclerosis

###### 

Click here for additional data file.
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